MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis

European Radiology

Volumn 10, Issue 11, 2000, Pages 1697-1702

  Bartolozzi, C ^a   Donati, F ^a   Cioni, D ^a   Crocetti, L ^a   Lencioni, R ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Cirrhosis; Hepatocellular carcinoma; MR contrast agents

Indexed keywords

IODINATED POPPYSEED OIL; MANGAFODIPIR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EVALUATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

CARCINOMA, HEPATOCELLULAR; EDETIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODIZED OIL; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIDOXAL PHOSPHATE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033788749     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300000564     Document Type: Article

References (18)

1. Hepatocellular carcinoma in Italian patients with cirrhosis
2. Contrast-enhanced MR imaging of the liver
3. Focal liver tumors: MR imaging with Mn-DPDP - Initial clinical results in 40 patients
4. Plasma pharmacokinetics, tissue distribution, and excretion of MnDPDP in the rat and dog after intravenous administration
5. Influence of the hepatobiliary contrast agent mangafodipir trisodium (Mn-DPDP) on the imaging properties of abdominal organs
6. MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies
7. Mn-DPDP-enhanced MRI in experimental bile duct obstruction
8. Differentiation of hepatomas from nonhepatomatous masses: Use of MnDPDP-enhanced MR images
9. Intrahepatic metastatic nodules of hepatocellular carcinoma detected at Lipiodol-CT: Imaging-pathologic correlation
10. Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: An overview of preclinical animal experiments
11. Uptake of mangafodipir trisodium (MnDPDP) by hepatocellular carcinoma correlation with unenhanced imaging findings and histopathologic features
12. Value of delayed MnDPDP enhanced imaging in the detection and differential diagnosis of hepatic tumors
13. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images
14. Benign and malignant hepatocellular tumors: Evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging
15. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP)
16. Small hepatocellular carcinoma: Differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging
17. Sequence optimization in mangafodipir trisodium-enhanced liver and pancreas MRI
18. Ethanol injection for the treatment of hepatic tumours